Isodiol International Inc. Announces Acquisition of Food Labs, Inc. and Strategic Investor Relationship with Toba Capital LLC
Cardiol Therapeutics: A Leader in Research and Commercial Development of Pharmaceutical Cannabidiol Products and Targeted Therapies for Heart Failure and Cancer
Sarepta Therapeutics Completes Submission of New Drug Application Seeking Approval of Golodirsen (SRP-4053)
Mustang Bio Receives Orphan Drug Designation for MB-102 (CD123 CAR T) for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm
Amicus Therapeutics Announces First Patient Dosed in Phase 3 PROPEL Pivotal Study of AT-GAA in Patients with Pompe Disease
Clearside Biomedical Submits New Drug Application for XIPERE for the Treatment of Macular Edema Associated with Uveitis
Relay Medical Corp. and AgraFlora Organics International Inc. Form Glow Life Technologies Ltd. for the Development of Medical Technologies in the Cannabis Sector
Cardiol Therapeutics Completes Initial Public Offering and the Company’s Common Shares and Warrants Commence Trading on the Toronto Stock Exchange Under the Symbols “CRDL” and “CRDL.WT”
MGX Minerals Announces Partnership with University of British Columbia to Develop Metallurgical Silicon Based Anode for High-Energy Lithium-Ion Batteries
Yield Growth Signs Agreements to Sell Cannabis Topicals Through 400 Store Distribution Network in Oregon
Flowr Expands into Global Markets by Acquiring 19.8% Of Large-Scale Portuguese and Australian Cannabis Producer Holigen
Brixton Metals Closes $2.78M Oversubscribed Private Placement and Provides Atlin Goldfields Project Update
Lilly and Aduro Biotech Announce Research Collaboration and License Agreement to Develop Novel Immunotherapies